Translational Development Acquisition (TDAC) Assets Average (2024 - 2026)

Translational Development Acquisition's Assets Average history runs 3 years deep, the most recent figure standing at $182.5 million for Q1 2026.

• Quarterly Assets Average rose 3.82% year-over-year to $182.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $182.5 million (up 3.82% YoY) and the FY2025 annual result came in at $178.3 million, up 103.82% from the prior year.
• Assets Average was $182.5 million for Q1 2026 at Translational Development Acquisition, up from $180.8 million in the prior quarter.
• Across five years, Assets Average topped out at $182.5 million in Q1 2026 and bottomed at $87.5 million in Q4 2024.
• A 3-year average of $163.9 million and a median of $178.2 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2025 — Assets Average surged 106.67% — and 2026, when it climbed 3.82%.
• Translational Development Acquisition's Assets Average stood at $87.5 million in 2024, then jumped by 106.67% to $180.8 million in 2025, then increased by 0.93% to $182.5 million in 2026.
• Business Quant data shows TDAC's Assets Average at $182.5 million in Q1 2026, $180.8 million in Q4 2025, and $179.1 million in Q3 2025.